DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
B••••• H••••• H•••••••• L••
H•••••care & Pharmaceuticalsgroup grade Aon a schedule nowsponsor A•••••••• I••••••••• M••••••••• L•• carried
Also written as: B••••• H••••• Intermediate Holdings; First Lien; First Lien - Undrawn; Wholly-owned subsidiaries
Principal held
at least $64.8M
sum of BDC pieces, a lower bound
Fair value
$63.9M
100c on cost, debt pieces
Unfunded
$9.1M
commitments not yet drawn
BDC lenders
6
5 on the latest quarter
Facilities
3
1 equity pieces beside them
Next maturity
May 1, 2028
$64.8M inside 24 months
On the tape since
Mar 31, 2024
latest Jun 30, 2026
Events
5
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $64.8M | 100c | S+475 bp | May 6, 2028 | 6 |
| second lien revolver second lien | unknown | n/a | unstated | 2 | |
| other lien unstated exited Dec 31, 2024 | unknown | n/a | unstated | 2 |
Equity pieces beside the debt: preferred equity ($10.1M fair value, 3 BDCs)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C•••••• C••••• S••••••••• I••• | term loan first lien Investment | N••••••••• I••••• | F•••• L••• D••• | $28.4M | $28.3M 100c | S+475 bp |
| C•••••• C••••• S••••••••• I••• | revolver second lien Investments | N••••••••• I••••• | F•••• and S••••• L••• D••• | R••••••• | n/a | n/a | |
| C•••••• S•••••• L••••••• I••• | revolver second lien Investments | N••••••••• | F•••• and S••••• L••• D••• | R••••••• | n/a | n/a | |
| C•••••• S•••••• L••••••• I••• | term loan first lien Investment | N••••••••• I••••• | F•••• L••• D••• | $28.4M | $28.3M 100c | S+475 bp |
| N•• M••••••• F•••••• C••• | term loan first lien F•••• lien | $3.0M | $3.0M 100c | S+475 bp |
| N•• M••••••• F•••••• C••• | term loan first lien F•••• lien - U•••••• | $417,000 | $0 0c | |
| N•• M••••••• P•••••• C••••• F••• | term loan first lien F•••• L••• | N••••••••• I••••• | $2.3M | $2.3M 100c | S+475 bp |
| N•• M••••••• P•••••• C••••• F••• | term loan first lien F•••• L••• U•••••• 1 | N••••••••• I••••• | $313,000 | $0 0c | |
| N•• S•• I• I••• | term loan first lien F•••• L••• - U•••••• | N••••••••• I••••• | n/a | $0 0c | |
| N•• S•• I• I••• | term loan first lien F•••• L••• | N••••••••• I••••• | $2.0M | $2.0M 100c | S+475 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 5 | $64.8M | $63.9M | 100c | 0 |
| Mar 31, 2026 | 5 | $64.8M | $64.0M | 100c | 0 |
| Dec 31, 2025 | 5 | $67.4M | $66.6M | 101c | 0 |
| Sep 30, 2025 | 5 | $65.0M | $64.1M | 101c | 0 |
| Jun 30, 2025 | 3 | $8.3M | $7.3M | 100c | 0 |
| Mar 31, 2025 | 3 | $15.6M | $14.6M | 100c | 0 |
| Dec 31, 2024 | 3 | $31.1M | $29.3M | 100c | 0 |
| Sep 30, 2024 | 3 | $15.7M | $14.8M | 101c | 0 |
| Jun 30, 2024 | 3 | $15.8M | $14.9M | 101c | 0 |
| Mar 31, 2024 | 3 | $15.8M | $14.9M | 101c | 0 |
What changed
- Maturity approachingMay 6, 2028
- Maturity extended (observed)Mar 31, 2026
- Maturity extended (observed)Mar 31, 2026
- Maturity extended (observed)Mar 31, 2026
- Maturity extended (observed)Sep 30, 2025
- New lender joined a facilitySep 30, 2025
- New lender joined a facilitySep 30, 2025
- Spread changed (observed)Jun 30, 2025
- New lender joined a facilityDec 31, 2024
- Facility left every BDC scheduleDec 31, 2024
- New borrower on a BDC scheduleMar 31, 2024
Sponsor
- A•••••••• I••••••••• M••••••••• L••
- the sponsor's own portfolio page lists a company of this nameestimatedarrowheadmgt.com"••• Locked"
Identity
- Group key
- BAMBOO HEALTHderivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 6 BDCsderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it